USPTO 2015–2025 USPTO PatentsView US Corporation

Quest Products, LLC

USPTO PatentsView assignee record - 10 granted patents across 9 technology areas, recorded in grant years 2019–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

RSS updates for this company

The verdict

According to USPTO PatentsView, Quest ranks #27,220 of 49,997 tracked US assignees by granted-patent volume, with 10 patents across 9 technology areas.

#27,220
of 49,997 US assignees by volume
47th percentile
by Innovation Score (34.2/100)
18.8
avg claims per patent
+67%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R27220 · US Corporation #27,220 · 10 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-MICRO 10 grants
  • MID-PACK #27,220/49,997
  • PHOTO-FINISH Qu Biologics
  • CPC-NARROW A61F · 9 areas
  • INNOV-THIN 34.2/100
  • CLAIMS-RICH 18.8 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-SURGE +67% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Qu Biologics Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Quest’s 34.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Quest

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Quest's Innovation Score is 34.2/100 (47th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Quest?

Each dot is one of Quest’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Quest’s own 18.8 claims/patent is ABOVE the 18.2 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Quest vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 9.99.91010.1 121416182022 Granted patents (volume) Avg claims / patent Qu Biologics Inc. - 10, 15.5Qu BiologicsQuallion LLC - 10, 18.8QuallionQuantum Source Labs Ltd. - 10, 20.6Quantum Source La…Queen Mary & Westfield College, University of London - 10, 14.3Queen Mary & West…Quintar, Inc. - 10, 19.6QuintarQuintiles IMS Incorporated - 10, 21.6Quintiles IMS Inc…R & D Tool & Engineering Co. - 10, 16.9R & D Tool & Engi…R&B Leasing, LLC - 10, 18.2R&B LeasingQuest Products, LLC - 10, 18.8Quest Products
Quest vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Quest's grants concentrate

Quest Products, LLC is a focused PatentsView assignee: 9 CPC subclasses with 50% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2019 (3 grants) versus a trough of 1 in 2020. By volume, Quest sits between Qu Biologics Inc. and R&B Leasing, LLC.

Quest's three-year grant acceleration

Quest Products, LLC shows 3 grants in 2022–2024 against only 5 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Quest's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Quest holds 10 patents at rank #27,210, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Quest

By rank, the assignees closest to #27,210 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Quest's primary technology class.

Quest's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

34 47th percentile higher than 47% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0.511.522.533.5 2019202020212022202320242025 2
USPTO utility patent grants by year · 2019–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.

View data table
Quest Products, LLC patent grants by year, 2015–2025
Year Patents Granted Share of Period
2019 3 30.0%
2020 1 10.0%
2021 1 10.0%
2022 1 10.0%
2023 1 10.0%
2024 1 10.0%
2025partial year 2 20.0%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Quest Products, LLC's patent record in context - here's where to go next.

  • Quest Products, LLC's lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 50% of its portfolio - see every assignee active in that class. Explore A61F
  • Ranked #27,220 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Quest Products, LLC against Qu Biologics Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 34.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.